The trademark application Finadox was filed by MIP Pharma GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on May 11, 2022, and it was registered by office on August 18, 2022 without any oppositions.
The application was filed in German (English was selected as the second language).